| Name | Title | Contact Details |
|---|
BA Insight`s software portfolio accelerates and future-proofs the creation of cloud-based and on-premise SharePoint portals for enterprises, transforming how users find information. Our software dramatically reduces the time, cost, effort, and risk of implementing SharePoint portals while providing a greatly improved user experience. Customers use our applications to improve productivity by finding the right information faster using Smart Previews and User-Generated InfoSites; our classification software to increase findability using auto-tagging, metadata generation, and text analytics; and our pre-built connectors and federation to provide secure connectivity to a wide variety of content systems.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Rightscorp (OTCQB: RIHT) is a leading provider of monetization services for artists and holders of copyrighted Intellectual Property (IP). The Company`s patent pending digital loss prevention technology focuses on the infringement of digital content such as music, movies, software, books, and games and ensures that owners and creators are rightfully paid for their IP. Rightscorp implements existing laws to solve copyright infringements by collecting payments from illegal file sharing activities via notifications sent through Internet Service Providers (ISPs). The Company`s technology identifies copyright infringers, who are offered a reasonable settlement option when compared to the legal liability defined in the Digital Millennium Copyrights Act (DMCA). Based on the fact that 22% of all Internet traffic is used to distribute copyrighted content without permission or compensation to the creators, Rightscorp is pursuing an estimated $2.3 billion opportunity and has monetized major media titles through relationships with industry leaders. Rightscorp`s mission is to ensure that creative works are protected economically so that the next generation of great music, movies, video games, books, and software can be made and their creators can prosper.
The patient engagement company for leading healthcare organizations. ONC 2015 certified patient portal, mobile app and patient engagement software vendor.